Each year more than two million hospital admissions in the U.S. are due solely to adverse drug reactions—and 180,000 of those result in death. [More]
- National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH), component of the U.S. Department of Health and Human Services. “Antidepressant Medications for Children and Adolescents: Information for Parents and Caregivers,” review date 4/21/2011: www.nimh.nih.gov/health/topics/child-and-adolescent-mental-health/antidepressant-medications-for-children-and-adolescents-information-for-parents-and-caregivers.shtml.
- U.S. Food and Drug Administration. “Guidance for Industry. Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products - Content and Format,” Jan. 2006: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm075096.pdf.